PJVK
Pejvakin
Also known as: DFNB59, PJVK_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q0ZLH3
- Gene
- PJVK
- Ensembl
- ENSG00000204311
- Chromosome
- 2
- Canonical length
- 352 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene is a member of the gasdermin family, a family which is found only in vertebrates. The encoded protein is required for the proper function of auditory pathway neurons. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal recessive type 59 (DFNB59). [provided by RefSeq, Dec 2008]
Canonical amino-acid sequenceUniProt
352 residues, UniProt reviewed canonical sequence.
>Q0ZLH3|PJVK
1 MFAAATKSFV KQVGDGGRLV PVPSLSEADK YQPLSLVVKK KRCFLFPRYK FTSTPFTLKD
61 ILLGDREISA GISSYQLLNY EDESDVSLYG RRGNHIVNDV GINVAGSDSI AVKASFGIVT
121 KHEVEVSTLL KEITTRKINF DHSLIRQSRS SRKAVLCVVM ESIRTTRQCS LSVHAGIRGE
181 AMRFHFMDEQ NPKGRDKAIV FPAHTTIAFS VFELFIYLDG AFDLCVTSVS KGGFEREETA
241 TFALLYRLRN ILFERNRRVM DVISRSQLYL DDLFSDYYDK PLSMTDISLK EGTHIRVNLL
301 NHNIPKGPCI LCGMGNFKRE TVYGCFQCSV DGQKYVRLHA VPCFDIWHKR MKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PJVK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- testis: 37 nTPM
- pituitary gland: 9.3 nTPM
- ovary: 8.1 nTPM
- liver: 7.2 nTPM
- basal ganglia: 7 nTPM
- cervix: 6.9 nTPM
Single-cell type
- late primary spermatocytes: 238 nCPM
- early spermatids: 224 nCPM
- late spermatids: 141 nCPM
- retinal ganglion cells: 50 nCPM
- megakaryocyte-erythroid progenitors: 44 nCPM
- enteric stem cells: 34 nCPM
Immune cell
- plasmacytoid DC: 2.8 nTPM
- naive B-cell: 0.6 nTPM
- naive CD4 T-cell: 0.5 nTPM
- neutrophil: 0.4 nTPM
- memory B-cell: 0.3 nTPM
- naive CD8 T-cell: 0.3 nTPM
Brain region
- medulla oblongata: 6.1 nTPM
- white matter: 6.1 nTPM
- cerebral cortex: 5.6 nTPM
- midbrain: 5.6 nTPM
- spinal cord: 5.4 nTPM
- basal ganglia: 5.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PJVK.
Disease | AllUniProt
Conditions PJVK is implicated in, by any mechanism.
- Deafness, autosomal recessive, 59 (DFNB59) MIM:610220
Disease | GeneticClinVar
46 pathogenic / likely-pathogenic of 297 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive nonsyndromic hearing loss 59
- Deafness
- Hearing loss, autosomal recessive
- PJVK-related disorder
- Ear malformation
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- detection of mechanical stimulus involved in sensory perception of sound
- pexophagy
- regulation of peroxisome organization
- response to reactive oxygen species
- sensory perception of sound
- stereocilium maintenance
- programmed cell death in response to reactive oxygen species
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PJVK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PJVK as an antibody target. Whether an autoantibody or antibody against PJVK could matter depends on whether native PJVK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PJVK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PJVK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...